Plasmin-induced procoagulant effects in the blood coagulation: A crucial role of coagulation factors v and VIII

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 6, 2010, Pages 568-576

  Ogiwara, Kenichi ^a   Nogami, Keiji ^a   Nishiya, Katsumi ^a   Shima, Midori ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

factor V; factor VIII; global coagulation assay; plasmin; procoagulant activity

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; PLASMIN;

ARTICLE; BLOOD CLOTTING; CATALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR V; FACTOR VIII; FIBRINOLYSIN; HUMANS;

EID: 77955924406     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833c9a9f     Document Type: Article

References (28)

1. Booth NA, Bachmann F. Plasminogen-plasmin system. In: Coleman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. Hemostasis and Thrombosis: basic principles and clinical practice, 5th edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. pp. 335-364.
2. Eisenberg PR, Sherman LA, Jaffe AS. Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol 1987; 10:527-529.
3. Rapold HJ, Kuemmerli H, Weiss M, Baur H, Haeberli A. Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator. Circulation 1989; 79:980-989.
4. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbeul W, Daniel WG, et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction: relevance for the success of therapy. Circulation 1991; 83:937-944.
5. Samis JA, Ramsey GD, Walker JB, Nesheim ME, Giles AR. Proteolytic processing of human coagulation factor IX by plasmin. Blood 2000; 95:943-951.
6. Pryzdial EL, Lavigne N, Dupuis N, Kessler GE. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor. J Biol Chem 1999; 274:8500-8505.
7. Laake K, Osterud B. Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system. Thromb Res 1974; 5:759-772.
8. Griffin JH. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci U S A 1978; 75:1998-2002.
9. Lee CD, Mann KG. Activation/inactivation of human factor V by plasmin. Blood 1989; 73:185-190.
10. Nogami K, Shima M, Matsumoto T, Nishiya K, Tanaka I, Yoshioka A. Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. J Biol Chem 2007; 282:5287-5295.
11. Ewald GA, Eisenberg PR. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation 1995; 91:28-36.
12. Hoffmeister HM, Szabo S, Kastner C, Beyer ME, Helber U, Kazmaier S, et al. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation 1998; 98:2527-2533.
13. Latacha MP, Schaiff WT, Eisenberg PR, Abendschein DR. Factor XIIdependent increases in thrombin activity induce carboxypeptidasemediated attenuation of pharmacological fibrinolysis. J Thromb Haemost 2004; 2:128-134.
14. Nogami K, Nishiya K, Saenko EL, Takeyama M, Tanaka I, Yoshioka A, et al. Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain. Biochim Biophys Acta 2008; 1784:753-763.
15. Nogami K, Nishiya K, Saenko EL, Takeyama M, Ogiwara K, Yoshioka A, et al. Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36. J Biol Chem 2009; 284:6934-6945.
16. Hoffmann M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85:958-965.
17. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27:81-90.
18. Braun PJ, Givens TB, Stead AG, Beck LR, Gooch SA, Swan RJ, et al. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost 1997; 78:1079-1087.
19. Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 2006; 4:377-384.
20. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15.
21. Shima M, Matsumoto T, Ogiwara K. New assays for monitoring haemophilia treatment. Haemophilia 2008; 14 (Suppl 3):83-92.
22. Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds JA. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry 1981; 20:833-840.
23. Huisse MG, Ajzenberg N, Feldman L, Guillin MC, Steg PG. Microparticlelinked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Thromb Haemost 2009; 101:734-740.
24. Eisenberg PR, Miletich JP, Sobel BE. Factors responsible for the differential procoagulant effects of diverse plasminogen activators in plasma. Fibrinolysis 1991; 5:217-224.
25. Church WR, Jernigan RL, Toole J, Hewick RM, Knopf J, Knutson GJ, et al. Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc Natl Acad Sci U S A 1984; 81:6934-6937.
26. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255:274-283.
27. van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256:3433-3442.
28. Nishiya K, Nogami K, Okada K, Matsuo O, Ogiwara K, Shima M. Lysinebinding site-dependent interaction with plasmin and factor Va responsible for plasmin-catalyzed factor Va inactivation. Blood 2008; 112:703; [abstract 2016].